Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Science

• Publication date

  2009-11-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/science.1171242PMID 19892975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomechanics: Barefoot running strikes back

  2010cited by this paper
• Faculty Opinions recommendation of Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.

  2010cited by this paper
• Acquired autoimmune polyglandular syndrome, thymoma, and an AIRE defect.

  2010cited by this paper
• Gene therapy for immunodeficiency due to adenosine deaminase deficiency.

  2009cited by this paper
• Inappropriate referencing in research

  2009cited by this paper
• IL-17 and Th17 Cells.

  2009cited by this paper
• A Comeback for Gene Therapy

  2009cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy.

  2009cited by this paper
• LNA-mediated microRNA silencing in non-human primates

  2008cited by this paper
• B cells are required for Aire-deficient mice to develop multi-organ autoinflammation: A therapeutic approach for APECED patients

  2008cited by this paper
• From bone marrow to microglia: barriers and avenues.

  2008cited by this paper
• High-resolution insertion-site analysis by linear amplification–mediated PCR (LAM-PCR)

  2007cited by this paper
• X-linked adrenoleukodystrophy

  2007cited by this paper
• Incidence and determinants of lower extremity running injuries in long distance runners: a systematic review

  2007cited by this paper
• Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice.

  2006cited by this paper
• Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

  2006cited by this paper
• Mutations in TNFRSF13B Encoding TACI Are Associated With Common Variable Immunodeficiency in Humans

  2006cited by this paper
• Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells.

  2005cited by this paper
• Hepatic β-oxidation and carnitine palmitoyltransferase I in neonatal pigs following dietary treatments of clofibric acid , isoproterenol and medium 2 chain triglycerides 4

  2005cited by this paper
• IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW，Thompson RW，et al//Proc Natl Acad Sci U S A

  2005cited by this paper
• Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein.

  2004cited by this paper
• Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector.

  2004cited by this paper
• LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

  2003cited by this paper
• Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice.

  2003cited by this paper
• Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.

  2002cited by this paper
• HIV-1 integration in the human genome favors active genes and local hotspots.

  2002cited by this paper
• Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein

  2002cited by this paper
• Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy.

  2002cited by this paper
• Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient.

  2002cited by this paper
• Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics

  2001cited by this paper
• Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment

  2001cited by this paper
• Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

  2000cited by this paper
• Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy.

  2000cited by this paper
• Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors.

  1999cited by this paper
• HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells.

  1998cited by this paper
• Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice.

  1997cited by this paper
• In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

  1996cited by this paper
• Adrenoleukodystrophy: a scoring method for brain MR observations.

  1994cited by this paper
• A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.

  1993cited by this paper
• Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters

  1993cited by this paper
• Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation.

  1990cited by this paper
• Blood.

  1989cited by this paper

• Viral vector research in human gene therapy: basic principles, alternative evaluation models, and clinical applications.

  2026cites this paper
• The Grey Zone Project: Risk‐Based Classification of ABCD1 Variants in X‐Linked Adrenoleukodystrophy

  2026cites this paper
• Viral and non-viral cellular therapies for neurodegeneration

  2026cites this paper
• Brain-wide microglia replacement using a nonconditioning strategy ameliorates pathology in mouse models of neurological disorders.

  2025cites this paper
• Donor insertion into CX3CR1 allows epigenetic modulation of a constitutive promoter on hematopoietic stem cells and its activation upon myeloid differentiation

  2025cites this paper
• Imagerie des affections métaboliques congénitales cérébrales

  2025cites this paper
• Impact of Promoter-Independent CpG-Rich A2UCOE Subregions on Transgene Expression

  2025cites this paper
• Dissection of Neurochemical Pathways Across Complexity and Scale

  2025cites this paper
• Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy

  2025cites this paper
• Survivin in cardiovascular diseases and its therapeutic potential.

  2025cites this paper
• The Metabolic Treatabolome and Inborn Errors of Metabolism Knowledgebase therapy tool: Do not miss the opportunity to treat!

  2025cites this paper
• Preclinical efficacy of a modified gamma-globin lentivirus gene therapy in Berkeley sickle cell anemia mice and human xenograft models

  2025cites this paper
• Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?

  2025cites this paper
• Hematopoietic (stem) cells—The elixir of life?

  2025cites this paper
• Advances in viral and nonviral delivery systems for therapeutic gene editing

  2025cites this paper
• X-linked adrenoleukodystrophy: literature review, description of clinical cases

  2025cites this paper
• Risk and Benefit Assessment of Gene Therapy with Lentiviral Vectors and Hematopoietic Stem Cells: The Skysona Case

  2025cites this paper
• Application of Gene Therapy to Oral Diseases

  2025cites this paper
• Targeting immune heterogeneity in liver metastases through in vivo genetic engineering.

  2025cites this paper
• Brain microenvironment orchestrates highly aggressive tumor variants: current trends and therapeutic approaches

  2025cites this paper
• Hematopoietic stem cell gene therapy of neurometabolic lysosomal storage diseases

  2025cites this paper
• Development of a rabbit model for adrenoleukodystrophy: A pilot study on gene therapy using rAAV9

  2025cites this paper
• Role of lncRNAs related to NRs in the regulation of gene expression

  2025cites this paper
• In vivo gene therapy: A strategy for mutations, degenerations, and tumors

  2025cites this paper
• Adrenoleukodystrophy: Current understanding of disease mechanisms, diagnosis, and therapeutic advances-a recent review.

  2025cites this paper
• Cell-Division-Independent Rapid Expression of DNA Delivered with α-Synuclein-Gold Nanoparticle Conjugates.

  2025cites this paper
• GroβT rapidly and reliably mobilizes primitive hematopoietic stem and progenitor cells in nonhuman primates

  2025cites this paper
• Development of Lentiviral Packaging Cells and Scale Up of Production to Meet the Growing Demand in Cell and Gene Therapy.

  2025cites this paper
• A scoping review of stem cell models of leukodystrophies: advances in understanding pathophysiological mechanisms

  2025cites this paper
• cMPL-Based Purification and Depletion of Human Hematopoietic Stem Cells: Implications for Pretransplant Conditioning.

  2025cites this paper
• Safety and efficacy of leriglitazone in childhood cerebral adrenoleukodystrophy (NEXUS): an interim analysis of an open-label, phase 2/3 trial

  2025cites this paper
• Retroviral Vector Technology for Gene Therapy: History, Current Landscape, and Future Prospects.

  2025cites this paper
• Neonatal microglia replacement in mice modulates seizure severity in adulthood

  2025cites this paper
• Status epilepticus as clinical manifestation of adrenomyeloneuropathy: a rare association

  2025cites this paper
• Mapping Hematopoietic Fate after Transplantation

  2025cites this paper
• Gene Therapy of Adrenomyeloneuropathy: Challenges, Target Cells, and Prospectives

  2025cites this paper
• Elovl1 inhibition reduced very long chain fatty acids in a mouse model of adrenoleukodystrophy

  2025cites this paper
• Stem cell and gene therapies for leukodystrophies

  2025cites this paper
• Newborn screening of neurometabolic diseases for early treatment.

  2025cites this paper
• Daedalus fragment from the CBX3 ubiquitous chromatin opening element as an optimum UCOE candidate

  2025cites this paper
• Navigating disruption in the PID landscape: embracing opportunities and anticipating threats in the next ten years

  2025cites this paper
• Hematopoietic stem cell gene therapy for the treatment of SYNGAP1‐related non‐specific intellectual disability

  2024cites this paper
• Viral/Non-Viral Vectors in DNA/RNA Delivery Technology

  2024cites this paper
• Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integration

  2024influential citation
• Gene therapy clinical trials worldwide to 2023—an update

  2024cites this paper
• Long-term lineage commitment in haematopoietic stem cell gene therapy

  2024cites this paper
• Haploinsufficiency at the CX3CR1 locus of hematopoietic stem cells favors the appearance of microglia-like cells in the central nervous system of transplant recipients

  2024cites this paper
• Weighing the Risks of Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy.

  2024cites this paper
• Oligodendrocytes, the Forgotten Target of Gene Therapy

  2024cites this paper
• From gene to therapy: a review of deciphering the role of ABCD1 in combating X-Linked adrenoleukodystrophy

  2024cites this paper
• Roles of blood monocytes carrying TREM2R47H mutation in pathogenesis of Alzheimer's disease and its therapeutic potential in APP/PS1 mice

  2024cites this paper
• Adrenoleukodystrophy: Symptoms, Treatment and Newborn Screening. Literature Review and Clinical Case

  2024cites this paper
• Gene therapy for the leukodystrophies: From preclinical animal studies to clinical trials

  2024cites this paper
• Paroxysmal delta waves of awake EEG in childhood adrenoleukodystrophy: Possible indicator of the hematopoietic stem cell therapy (HSCT).

  2024cites this paper
• Emerging trends in virus and virus-like particle gene therapy delivery to the brain

  2024cites this paper
• Ethics of gene and cell therapy development for neurologic disorders.

  2024cites this paper
• Hematopoietic stem cell gene therapy to halt neurodegeneration

  2024cites this paper
• A case of adrenomyeloneuropathy caused by a novel point mutation in the ABCD1 gene and functional verification

  2024influential citation
• Hematopoietic stem cell therapy and ex vivo gene therapy for X-linked adrenoleukodystrophy.

  2024cites this paper
• Gene Therapy Strategies for RAG1 Deficiency: Challenges and Breakthroughs.

  2024cites this paper
• Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene Therapy

  2024cites this paper
• Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy.

  2024cites this paper
• CNS-wide repopulation by hematopoietic-derived microglia-like cells corrects progranulin deficiency in mice

  2024cites this paper
• Phase I clinical trial of intracerebral injection of lentiviral-ABCD1 for the treatment of cerebral adrenoleukodystrophy.

  2024cites this paper
• Pathophysiology of X-Linked Adrenoleukodystrophy: Updates on Molecular Mechanisms

  2024cites this paper
• Biomimetic cell stimulation with a graphene oxide antigen-presenting platform for developing T cell-based therapies

  2024cites this paper
• Sleeping Beauty mRNA-LNP enables stable rAAV transgene expression in mouse and NHP hepatocytes and improves vector potency.

  2024cites this paper
• Mission possible: Gene therapy for inherited metabolic diseases

  2024cites this paper
• Non-clinical safety assessment of novel drug modalities: Genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapies.

  2024cites this paper
• In vivo adenine base editing rescues adrenoleukodystrophy in a humanized mouse model.

  2024cites this paper
• Long-term benefits of hematopoietic stem cell-based macrophage/microglia delivery of GDNF to the CNS in a mouse model of Parkinson’s disease

  2024cites this paper
• International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges faced.

  2024cites this paper
• The pathology of X-linked adrenoleukodystrophy: tissue specific changes as a clue to pathophysiology

  2024cites this paper
• Non‐viral Gene Therapy for Melanoma Using Lysenin from Eisenia Foetida

  2024cites this paper
• An empowered, clinically-viable hematopoietic stem cell gene therapy approach for the treatment of multisystemic Mucopolysaccharidosis Type II.

  2024cites this paper
• cMPL-Based Purification and Depletion of Human Hematopoietic Stem Cells: Implications for Pre-Transplant Conditioning

  2024cites this paper
• Modeling integration site data for safety assessment with MELISSA

  2024cites this paper
• Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies

  2024cites this paper
• Nanoplatform-Based In Vivo Gene Delivery Systems for Cancer Therapy.

  2024cites this paper
• Gene therapy for rare haematological and neurometabolic paediatric diseases

  2024cites this paper
• Therapeutic efficacy of intracerebral hematopoietic stem cell gene therapy in an Alzheimer’s disease mouse model

  2024cites this paper
• Recent advances in hematopoietic gene therapy for genetic disorders.

  2023cites this paper
• Efficacy of HDAC Inhibitors in Driving Peroxisomal β-Oxidation and Immune Responses in Human Macrophages: Implications for Neuroinflammatory Disorders

  2023cites this paper
• Elivaldogene autotemcel approved for treatment of cerebral adrenoleukodystrophy (CALD) in males: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)

  2023cites this paper
• Partial correction of immunodeficiency by lentiviral vector gene therapy in mouse models carrying Rag1 hypomorphic mutations

  2023cites this paper
• Immune response of BV-2 microglial cells is impacted by peroxisomal beta-oxidation

  2023cites this paper
• X-linked adrenoleukodystrophy and primary adrenal insufficiency

  2023cites this paper
• Clonal tracking in cancer and metastasis

  2023cites this paper
• Tagged IDS causes efficient and engraftment-independent prevention of brain pathology during lentiviral gene therapy for Mucopolysaccharidosis type II

  2023cites this paper
• Gene and Cellular Therapies for Leukodystrophies

  2023cites this paper
• Pediatric Drug Development: Reviewing Challenges and Opportunities by Tracking Innovative Therapies

  2023cites this paper
• Successes and challenges in clinical gene therapy

  2023cites this paper
• Prostaglandin E2 as transduction enhancer affects competitive engraftment of human hematopoietic stem and progenitor cells

  2023cites this paper
• Induced Pluripotent Stem Cells in Disease Biology and the Evidence for Their In Vitro Utility.

  2023cites this paper
• Advances and Challenges in the Development of Gene Therapy Medicinal Products for Rare Diseases

  2023cites this paper
• Current and Future Perspective in Hematopoietic Stem Progenitor Cell-gene Therapy for Inborn Errors of Metabolism

  2023cites this paper
• History of Gene Therapy

  2023cites this paper
• Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy

  2023cites this paper
• Rescue of Alzheimer’s disease phenotype in a mouse model by transplantation of wild-type hematopoietic stem and progenitor cells

  2023cites this paper
• Genetic engineering strategy for generating a stable dsRNA virus vector using a virus-like codon-modified transgene

  2023cites this paper